Medicare Enrolled
Dr. William Dilorenzo, D.O.
Nuclear Cardiology Physician · Toms River, NJ
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dilorenzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dilorenzo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dilorenzo
Dr. William Dilorenzo is a nuclear cardiology physician in Toms River, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dilorenzo performed 3,031 Medicare services across 2,273 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dilorenzo received a total of $20,435 from 41 pharmaceutical and/or device companies across 1033 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dilorenzo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 48% volume in NJ
$20,435 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,031
Medicare services
Top 48% in NJ for nuclear cardiology physician
2,273
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
319 | $57 | $580 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
314 | $98 | $820 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
281 | $11 | $96 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
228 | $51 | $431 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
216 | $28 | $261 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
179 | $18 | $159 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
175 | $16 | $153 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
174 | $138 | $1,232 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
161 | $66 | $517 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
118 | $19 | $186 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
110 | $94 | $758 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
109 | $17 | $133 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
109 | $11 | $88 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
101 | $107 | $853 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
67 | $129 | $1,253 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
66 | $19 | $164 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
59 | $26 | $227 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $90 | $812 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
45 | $13 | $125 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
45 | $12 | $113 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
16 | $13 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $112 | $1,087 |
| Heart muscle strain imaging | 15 | $10 | $261 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
15 | $16 | $93 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
13 | $88 | $681 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
13 | $3 | $128 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
12 | $15 | $114 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.1% high complexity
14.4% medium
65.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,435
Total received (2018-2024)
Avg $2,919/year across 7 years
Top 23% in NJ for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,033
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,371 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,332
2023
$1,719
2022
$3,367
2021
$3,109
2020
$2,569
2019
$2,927
2018
$2,413
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,787
AstraZeneca Pharmaceuticals LP
$628
E.R. Squibb & Sons, L.L.C.
$411
Medtronic, Inc.
$278
Novartis Pharmaceuticals Corporation
$278
CVRx, Inc.
$186
Edwards Lifesciences Corporation
$168
PFIZER INC.
$148
Amgen Inc.
$106
Esperion Therapeutics, Inc.
$64
Merck Sharp & Dohme LLC
$47
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$44
iRhythm Technologies, Inc.
$36
Kestra Medical Technology Services, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Baxter Healthcare
$27
Abbott Laboratories
$25
Janssen Pharmaceuticals, Inc
$21
Actelion Pharmaceuticals US, Inc.
$15
Top 3 companies account for 65.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,758
Boston Scientific Corporation
$2,584
E.R. Squibb & Sons, L.L.C.
$1,879
Novartis Pharmaceuticals Corporation
$1,369
Janssen Pharmaceuticals, Inc
$1,239
PFIZER INC.
$1,094
Amarin Pharma Inc.
$1,032
Amgen Inc.
$995
Medtronic, Inc.
$798
SANOFI-AVENTIS U.S. LLC
$569
Abbott Laboratories
$526
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$514
Medtronic Vascular, Inc.
$372
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
Merck Sharp & Dohme LLC
$266
Gilead Sciences, Inc.
$199
Edwards Lifesciences Corporation
$196
CVRx, Inc.
$186
Novo Nordisk Inc
$172
iRhythm Technologies, Inc.
$164
Endologix, LLC
$147
Kowa Pharmaceuticals America, Inc.
$145
ARBOR PHARMACEUTICALS, INC.
$144
Merck Sharp & Dohme Corporation
$130
Regeneron Healthcare Solutions, Inc.
$110
Actelion Pharmaceuticals US, Inc.
$89
Esperion Therapeutics, Inc.
$78
Alnylam Pharmaceuticals Inc.
$72
ARALEZ PHARMACEUTICALS US INC.
$68
Kestra Medical Technology Services, Inc.
$33
Daiichi Sankyo Inc.
$30
PORTOLA PHARMACEUTICALS, INC.
$29
Astellas Pharma US Inc
$28
Baxter Healthcare
$27
Kiniksa Pharmaceuticals, Ltd.
$26
Itamar Medical Inc
$21
W. L. Gore & Associates, Inc.
$16
Allergan Inc.
$15
Lundbeck LLC
$15
Vifor Pharma, Inc.
$14
Relypsa, Inc.
$13
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ACCOLADE SR · AFX · ANDEXXA · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · Corlanor · DYNAGEN · ELIQUIS · ENTRESTO · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Endurant · Epic Stented Tissue Valve · FARXIGA · GORE CARDIOFORM Septal Occluder · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · INVOKANA · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LYNPARZA · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE EL ICD VR · REVEAL LINQ · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · SYMPLICITY G3 · Supera peripheral stent system · Trifecta GT Tissue Heart Valve · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO · ZIO Patch · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nuclear cardiology physicians within 10 mi
9
Per 100K population
1.4
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dilorenzo is a remote & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dilorenzo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dilorenzo performed 319 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dilorenzo receive payments from pharmaceutical companies?
Yes. Dr. Dilorenzo received a total of $20,435 from 41 companies across 1,033 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dilorenzo's costs compare to other nuclear cardiology physicians in Toms River?
Dr. Dilorenzo's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dilorenzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Toms River
Browse nuclear cardiology physicians in Toms River ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in NJ
Nuclear cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in NJ
Which NJ nuclear cardiology physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology